Silo Pharma, Inc
Price
FilingsNewest: 8-K, Material agreementOct 2 →Insiders1 insider bought $7,660 in 6 open-market buys. No sales.→HoldersAdvisorShares Investments 6.7%Citadel 1.5%Vanguard 1.1%→Financing →PeersClosest companies: ARTL, RKTO, ENVB→
From the filings
Figures
- Revenue
- $72,102last 12 months
- Net income
- −$4.5Mlast 12 months
- Operating cash flow
- −$3.8Mlast 12 months
- Cash and equivalents
- $3.3Mat the last balance sheet
- Shares outstanding
- 1.1M shareson issue